全部

1·Renal fibrosis is the unifying feature of progressive renal alterations.

肾纤维化是肾脏改变的渐进统一的功能。

2·Extracellular matrix (ECM) accumulation is the final pathway to renal fibrosis.

细胞外基质(ecm)积聚是肾脏纤维化的最终途径。

3·Renal fibrosis is is the common pathway for a variety of chronic renal disease to final stage renal failure.

肾纤维化是各种慢性肾脏疾病进展到终末期肾衰竭的共同通路。

4·The relationships between expression of E2F-1 and degree of hydronephrosis and renal fibrosis were evaluated.

分析e2 F - 1表达与梗阻性肾积水和肾纤维化程度之间关系。

5·Objective To explore the curative effects of 1 (3 fluorophenyl) 5 methyl 2 (1H) pyridone (FMP) on renal fibrosis in rats.

目的：探讨1 （3 氟苯基） 5 甲基2 （1H）吡啶酮对鼠肾纤维化的治疗作用。

6·Multiple causes can induce CKD but it is renal fibrosis that is commonly recognized as the single factor that leads to ESRD.

导致CKD发生原因可以多种多样，但进展至esrd的共同途径是肾脏纤维化。

7·Objective:To probe into the mechanism of Shenshuai Capsule in delaying advance of chronic renal failure(CRF)and against interstitial renal fibrosis.

目的：探讨肾衰胶囊延缓慢性肾功能衰竭（CRF）进展及抗肾间质纤维化的机理。

8·The proliferation of GMC can induce extracellular matrix(ECM) expansion, which can lead to glomerulosclerosis(GS), renal fibrosis and even end stage renal failure in the final.

GMC增殖可引起细胞外基质（ECM）过量生成和聚集，并最终导致肾小球硬化（GS）、肾脏纤维化及终末期肾功能衰竭。

9·ObjectiveTo study the role and significance of plasminogen activator inhibitor-1(PAI-1) in renal fibrosis(RF) after damage and elucidate the molecular pathogenetic mechanisms of RF.

为探讨纤溶酶原激活物抑制因子1（PAI 1）在肾损伤后纤维化中的作用和意义，揭示其发病的分子病理机制。

10·In Belgium, at least 70 people required renal transplants or dialysis for interstitial fibrosis of the kidney after taking the wrong herb from the Aristolochiaceae family, again as a dietary aid.

在比利时，至少有70个人在不正确地采用马兜铃科草药作为助食品而需要肾移植或因肾间质纤维化而做透析。